ArticleInvestigative ophthalmology & visual science2025
Peptide Lv Deficiency Adversely Impacts the Structural and Functional Integrity of the Neural Retina.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Purpose: Peptide Lv (PLv) is a small endogenous secretory peptide expressed in various organs, including the retina and brain. It augments the protein expression and current densities of the L-type voltage-gated calcium channels in photoreceptors, hence the name peptide "Lv." However, its physiological function in the neural retina remains unknown. This study aims to determine the role of PLv in the retina using PLv null (PLv-/-) mice. Methods: Both male and female PLv-/- and age-matched control (PLv+/+) littermates were assessed longitudinally. The retinal light responses were examined using dark-adapted electroretinography (ERG). The thicknesses for whole retinas and various retinal layers were evaluated through spectral-domain optical coherence tomography (SD-OCT) and hematoxylin and eosin staining of retinal sections. Results: Dark-adapted ERG a-wave, b-wave, and oscillatory potentials were compromised in PLv-/- mice, which were more severe in females at younger ages. The whole retina and outer nuclear layer in PLv-/- mice were progressively thinner than the controls, as observed in SD-OCT imaging, which was corroborated by the histologic analyses of retinal sections. The progression of age-related retinal thinning was significantly slower in females than in males in both PLv-/- and PLv+/+ mice. Conclusions: Peptide Lv contributes to the maintenance of the structural and functional integrity of adult retinas, and its deficiency accelerates retinal degeneration. These findings highlight a potential neuroprotective role of peptide Lv in the retina.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.